EU GMP Annex 1 Training Online — The 2022 Revision and What It Requires

EU GMP Annex 1 is the regulatory framework that governs the manufacture of sterile medicinal products for the European market. The 2022 revision, in force since 25 August 2023, introduced the most significant changes to sterile manufacturing expectations in fourteen years. For quality and manufacturing professionals working in or supplying to the EU market, current Annex 1 training is not optional — it is a regulatory requirement under Section 2.1 of the guideline itself.

This guide explains what the 2022 Annex 1 requires in terms of training, what effective online Annex 1 training should cover and the key areas where inspection gaps are being found two years after the guidance came into force.

What Annex 1 says about training

Section 2.1 of EU GMP Annex 1 is explicit. All personnel who work in or enter classified areas must receive initial and ongoing training covering microbiology, contamination control and personal hygiene. Personnel performing aseptic operations must receive specific additional training in aseptic technique, garbing qualification and contamination prevention. The training programme must be qualified and personnel must be monitored for compliance.

Section 2.2 adds that training records must be maintained and that retraining and requalification must occur when a person has not performed aseptic operations for a defined period. An operator who has not performed a Grade A intervention for an extended time must demonstrate competence before being permitted to return to critical zone work.

This is not a general training obligation. Annex 1 training is a specific, documented and monitored requirement with direct inspection consequences if it cannot be demonstrated.

What the 2022 revision changed

The 2022 Annex 1 revision was the first update since 2008. The fourteen-year gap meant the previous version pre-dated significant developments in risk management, contamination control science and barrier technology. The key changes that training programmes must address include the following.

The Contamination Control Strategy (CCS) is the single most significant addition to the 2022 revision. Section 2.3 requires every sterile manufacturing site to develop, implement and maintain a documented CCS covering all sixteen elements defined in Section 2.5. Two years into the implementation period, inadequate CCS documentation and a lack of CCS integration into site operations are the most common inspection findings.

Rapid Microbiological Methods (RMM) assessment is now explicitly required within the CCS under Section 9. Sites must document whether they have assessed the feasibility of RMM adoption, even if they have decided not to implement. An absence of any RMM assessment in the CCS is a non-compliance finding.

RABS and isolator technology is now established as the expected minimum approach for aseptic processing in Section 4.3. Sites continuing to use open Grade A filling without a risk-based justification documented in the CCS are receiving observations.

Environmental monitoring requirements were expanded and clarified, including the requirement for trend analysis and the connection between EM data and the CCS. The 15-20 minute clean-up period to demonstrate return to at-rest conditions after operations is a new addition.

The training gap inspectors are finding

Two years of post-implementation inspections have identified a consistent training gap. Many sites completed Annex 1 awareness training before August 2023 — explaining what changed at a high level. Fewer sites have delivered the deeper regulatory understanding training that allows production supervisors, microbiologists and QA professionals to apply the revised requirements correctly when they encounter situations the SOP does not cover.

The questions inspectors ask go beyond awareness. They ask production staff directly what the contamination control strategy is for their area. They ask microbiologists to explain the scientific basis for their EM limits. They ask QA teams how deviations feed back into the CCS. Answering these questions correctly requires genuine regulatory understanding, not awareness of headlines.

What effective Annex 1 online training covers

An online training programme for EU GMP Annex 1 that prepares professionals for inspections and real-world implementation should address all of the following.

The full structure of the 2022 revision — all nine sections — including what changed from the 2008 version and why, not just a list of new requirements. Understanding the intent behind a requirement is what allows you to apply it to situations not explicitly described.

Contamination Control Strategy in depth — the sixteen elements of Section 2.5, how to build a CCS that functions as a living system rather than a static document, and how to connect it to environmental monitoring data, deviations and management review.

Current inspection findings — what inspectors from EMA and national competent authorities have been observing in sterile site inspections since August 2023. Training built from current inspection data is more actionable than training built from the guideline text alone.

The intersection with other regulations — how Annex 1 connects to ICH Q9 quality risk management, ICH Q10 pharmaceutical quality system, FDA aseptic processing guidance and USP compendial requirements for sterile products.

GMPify Annex 1 training

GMPify covers EU GMP Annex 1 (2022) across two dedicated courses — EU GMP Annex 1 (2022) Sterile Manufacturing, covering all nine sections of the guideline with current inspection data current to 2026, and Contamination Control Strategy (CCS), covering all sixteen CCS elements, the three contamination vectors and the ECA Foundation CCS approach.

Both courses include knowledge check questions and completion certificates. They are included in the GMPify subscription at $69/month alongside 28 additional courses covering FDA CGMP regulations, ICH guidelines, data integrity, process validation, microbiology and emerging topics.